Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Regulus Therapeutics Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 28 | 27 | −1 |
| Shares | 8.12M | 8.05M | −72.8K (−0.9%) |
| Value | $11.1M | $6.82M | −$4.30M (−38.7%) |
New holders (4)
Institutions that held Regulus Therapeutics Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 18,189 | $15.4K | 0.00% |
| LPL Financial LLC | 13,502 | $11.4K | 0.00% |
| Grimes & Company, Inc. | 10,363 | $8.78K | 0.00% |
| Barclays PLC | 5 | $4 | 0.00% |
Sold out (5)
Institutions that held Regulus Therapeutics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Dimensional Fund Advisors LP | 31,618 | $43.0K |
| Bank of America Corp | 18 | $24 |
| Morgan Stanley | 15 | $21 |
| Simplex Trading, LLC | 301 | $0 |
| Rockefeller Capital Management L.P. | 1 | $0 |